Anumana and Pfizer Partner to Enable Early Detection of Underdiagnosed Cardiovascular Disease
Related Articles
Anumana Acquires NeuTrace, Establishing a Comprehensive Electrophysiology Deep-Learning Development Platform and Product Pipeline
Anumana acquires NeuTrace, a medical technology company advancing novel in-procedure AI applications for electrophysiology (EP){post_date: F d, Y}
Anumana Announces Issuance of New American Medical Association CPT Category III Codes for Novel ECG AI Analysis of Cardiac Dysfunction
IT Business Net: Anumana, Inc., an AI-driven health technology company from nference, Inc., today announced the American Medical Association (AMA) has issued new industry-first Category III Current Procedural Terminology (CPT)…{post_date: F d, Y}
Anumana expands AI cardiac care platform with support from Boston Scientific
Anumana announced today that it brought its diagnostic ECG-AI technology into perioperative and acute cardiac care with help from Boston Scientific. Read more on massdevice.com{post_date: F d, Y}
Mayo Clinic launches two companies to tap patient data for AI tools
STAT News: Mayo Clinic is launching two new companies as part of its bid to harness patient data and use it to deliver AI-guided care.{post_date: F d, Y}